(Q47435138)

16 January 2018

title

Evaluation of BBG2Na in infant macaques: specific immune responses after vaccination and RSV challenge (English)

1 reference

16 January 2018

author

Ultan F. Power

2

1 reference

16 January 2018

Hubert G.M. Niesters

6

1 reference

16 January 2018

Ab Osterhaus

8

1 reference

16 January 2018

Rik L. de Swart

object named as

Rik L de Swart

7

0 references

Geert van Amerongen

4

object named as

Geert van Amerongen

1 reference

16 January 2018

Selma Yüksel

3

object named as

Selma Yüksel

1 reference

16 January 2018

author name string

Leon de Waal

1

1 reference

16 January 2018

Thien N Nguyen

5

1 reference

16 January 2018

language of work or name

English

0 references

publication date

1 February 2004

1 reference

16 January 2018

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

16 January 2018

volume

22

1 reference

16 January 2018

issue

8

1 reference

16 January 2018

page(s)

915-922

1 reference

16 January 2018

Respiratory syncytial virus infection

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.008

Respiratory syncytial virus vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.008

Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.008

Altered reactivity to measles virus. Atypical measles in children previously immunized with inactivated measles virus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.008

Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.008

Immunization of macaques with formalin-inactivated respiratory syncytial virus (RSV) induces interleukin-13-associated hypersensitivity to subsequent RSV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.008

Immunopathogenesis of vaccine-enhanced RSV disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.008

A role for immune complexes in enhanced respiratory syncytial virus disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.008

Respiratory syncytial virus immunobiology and pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.008

Induction of protective immunity in rodents by vaccination with a prokaryotically expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.008

Challenge of BALB/c mice with respiratory syncytial virus does not enhance the Th2 pathway induced after immunization with a recombinant G fusion protein, BBG2NA, in aluminum hydroxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.008

Absence of lung immunopathology following respiratory syncytial virus (RSV) challenge in mice immunized with a recombinant RSV G protein fragment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.008

Differential histopathology and chemokine gene expression in lung tissues following respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV- or BBG2Na-immunized mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.008

Enhanced pulmonary immunopathology following neonatal priming with formalin-inactivated respiratory syncytial virus but not with the BBG2NA vaccine candidate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.008

Protective efficacy against respiratory syncytial virus following murine neonatal immunization with BBG2Na vaccine: influence of adjuvants and maternal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.008

Safety and immunogenicity of a novel recombinant subunit respiratory syncytial virus vaccine (BBG2Na) in healthy young adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.008

A novel bipolar mode of attachment to aluminium-containing adjuvants by BBG2Na, a recombinant subunit hRSV vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.008

Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.008

10.1016/J.VACCINE.2003.10.008

7 January 2021

Identifiers

DOI

1 reference

16 January 2018

release_2az6r4johrgrxexuelezqzet7m

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2az6r4johrgrxexuelezqzet7m

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

15161068

1 reference

16 January 2018